📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Tetracyclines improve experimental lymphatic filariasis pathology by disrupting interleukin-4 receptor-mediated lymphangiogenesis. (2021)

First Author: Furlong-Silva J
Attributed to:  Is targeting vascular remodelling by filarial parasites a viable anti-morbidity solution? funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci140853

PubMed Identifier: 33434186

Publication URI: http://europepmc.org/abstract/MED/33434186

Type: Journal Article/Review

Volume: 131

Parent Publication: The Journal of clinical investigation

Issue: 5

ISSN: 0021-9738